Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash Flows from Operating Activities
Net income	$ 1,965.8	$ 1,930.0
Adjustments to Reconcile Net Income to Cash Flows from Operating Activities:
Depreciation and amortization	1,152.0	1,084.3
Change in deferred income taxes	350.8	(671.0)
Stock-based compensation expense	188.5	159.4
Net payments for terminations of interest rate swaps	(3.4)	(186.1)
Acquired in-process research and development	0.0	336.0
Other changes in operating assets and liabilities, net of acquisitions and divestitures	(1,215.8)	(963.6)
Other non-cash operating activities, net	296.2	279.5
Net Cash Provided by Operating Activities	2,734.1	1,968.5
Cash Flows from Investing Activities
Net purchases of property and equipment	(627.2)	(686.0)
Proceeds from sales and maturities of short-term investments	1,245.9	1,585.8
Purchases of short-term investments	(425.7)	(764.2)
Proceeds from sales of noncurrent investments	1,606.8	2,271.8
Purchases of noncurrent investments	(3,640.7)	(2,673.4)
Restricted cash released for acquisition	0.0	5,405.6
Cash paid for acquisitions, net of cash acquired	(45.0)	(5,287.8)
Proceeds from sale of product rights	0.0	410.0
Purchase of in-process research and development	0.0	(386.0)
Other investing activities, net	(75.1)	(102.7)
Net Cash Used for Investing Activities	(1,961.0)	(226.9)
Cash Flows from Financing Activities
Dividends paid	(1,617.4)	(1,594.0)
Net change in short-term borrowings	(1.7)	(2,680.7)
Proceeds from issuance of long-term debt	1,206.6	4,454.6
Repayment of long-term debt	(0.2)	(1,950.6)
Purchases of common stock	(300.1)	(496.6)
Other financing activities, net	(121.8)	27.7
Net Cash Used for Financing Activities	(834.6)	(2,239.6)
Effect of exchange rate changes on cash and cash equivalents	(115.9)	(134.8)
Net decrease in cash and cash equivalents	(177.4)	(632.8)
Cash and cash equivalents at January 1	3,666.4	3,871.6
Cash and Cash Equivalents at September 30	$ 3,489.0	$ 3,238.8